Effects of paroxetine on heart period variability in patients with panic disorder: a study of holter ECG records.
We investigated cardiac autonomic function in 16 patients with panic disorder before and after treatment with paroxetine using Holter ECG records. Our previous data suggest a relative increase in sympathetic activity in patients with panic disorder, especially during sleep. Data for 20 h and awake and sleep periods were analyzed using spectral analysis to quantify absolute and relative heart period variability in ultra low (ULF: <0.0033 Hz), very low (VLF: 0.0033-0.04 Hz), low (LF: 0.04-0.15 Hz) and high (HF: 0.15-0.5 Hz) frequency bands. We also obtained fractal dimensions (FD) for the 20-hour, awake and sleep time series of RR intervals. Paroxetine treatment (19.7 +/- 4.7 mg/day for 105 +/- 37 days) resulted in a significant improvement in the frequency and intensity of panic attacks and also on the state anxiety inventory. Paroxetine treatment produced a significant decrease of 20-hour absolute HF power, awake absolute LF power and sleep absolute HF power. There was also a significant decrease of FDs after treatment with paroxetine for the sleep period. The decrease in LF and HF powers, and sleep FD is likely due to the antimuscarinic effect of paroxetine. The decrease in day-time LF power may also be due to a decrease in relative cardiac sympathetic activity after paroxetine treatment.
Yeragani
V K
VK
Department of Psychiatry, Veterans Affairs Medical Center, Dayton, Ohio, USA. vikramyershr@yahoo.com
Jampala
V C
VC
Sobelewski
E
E
Kay
J
J
Igel
G
G
D000328:Adult; D015716:Electrocardiography, Ambulatory / Q000187:drug effects*; D005260:Female; D017709:Fractals; D006339:Heart Rate / Q000187:drug effects*; D006801:Humans; D008297:Male; D016584:Panic Disorder / Q000188:drug therapy* / Q000503:physiopathology*; D017374:Paroxetine / Q000627:therapeutic use*; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*
D017374:Paroxetine; D017367:Selective Serotonin Reuptake Inhibitors